- Home
- INVA vs HDL Comparison
INVA vs HDL Comparison
Compare INVA & HDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INVA
- HDL
- Stock Information
- Founded
- INVA 1996
- HDL 2016
- Country
- INVA United States
- HDL Singapore
- Employees
- INVA N/A
- HDL N/A
- Industry
- INVA Biotechnology: Pharmaceutical Preparations
- HDL Restaurants
- Sector
- INVA Health Care
- HDL Consumer Discretionary
- Exchange
- INVA Nasdaq
- HDL Nasdaq
- Market Cap
- INVA 1.1B
- HDL 1.1B
- IPO Year
- INVA 2004
- HDL 2024
- Fundamental
- Price
- INVA $18.20
- HDL $17.43
- Analyst Decision
- INVA Buy
- HDL
- Analyst Count
- INVA 5
- HDL 0
- Target Price
- INVA $35.60
- HDL N/A
- AVG Volume (30 Days)
- INVA 751.9K
- HDL 1.2K
- Earning Date
- INVA 11-06-2025
- HDL 11-24-2025
- Dividend Yield
- INVA N/A
- HDL N/A
- EPS Growth
- INVA N/A
- HDL 197.81
- EPS
- INVA 0.53
- HDL 0.09
- Revenue
- INVA $370,229,000.00
- HDL $805,433,000.00
- Revenue This Year
- INVA $7.98
- HDL $11.57
- Revenue Next Year
- INVA $11.60
- HDL $12.00
- P/E Ratio
- INVA $34.14
- HDL $20.71
- Revenue Growth
- INVA 12.02
- HDL 9.65
- 52 Week Low
- INVA $16.52
- HDL $15.54
- 52 Week High
- INVA $22.00
- HDL $30.00
- Technical
- Relative Strength Index (RSI)
- INVA 53.80
- HDL 38.44
- Support Level
- INVA $17.45
- HDL $17.51
- Resistance Level
- INVA $18.45
- HDL $17.66
- Average True Range (ATR)
- INVA 0.53
- HDL 0.26
- MACD
- INVA 0.15
- HDL -0.02
- Stochastic Oscillator
- INVA 74.01
- HDL 34.93
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
About HDL SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares
Super Hi International Holding Ltd is an investment holding company and its subsidiaries are principally engaged in restaurant operations, delivery business, and sales of hot pot condiment products and food ingredients located in the overseas market outside Mainland China, Hong Kong, Macau, and Taiwan. It mission is to become a global integrated restaurant group, build the world's Chinese cuisine brand, and promote Chinese culinary heritage world-wide.